NFKB1 and renal fibrosis: Selective antagonist of the CCR5 receptor, it is capable of reducing renal fibrosis and infiltration of CD4 T cells. In endothelial cells, it was able to reduce reactive oxygen species, decrease NFkB activation, reduce the expression of NOX1 (NADPH oxidase 1 complex), and restore nitric oxide production.